JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• Articles • Previous Articles     Next Articles

Expression of LATS1 and LATS2 in primary glioma by SYBRGreen quantitative realtime PCR

JIANG Zheng1, HU Jin2, LI Xingang3, LU Daru4, JIANG Yuquan3   

  1. 1. Laboratory of Neurosurgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;2. Department of Neurosurgery, Sixth People′s Hospital, Jiao Tong University, Shanghai 200233, China;
  • Received:2005-10-29 Revised:1900-01-01 Online:2006-12-24 Published:2006-12-24
  • Contact: JIANG Zheng

Abstract: To detect the expression of LATS1 and LATS2 mRNA in human primary glioma by SYBR Green quantitative realtime PCR, and to analyse the relationship between the expression and the clinical data. Methods: The method of SYBR Green quantitative realtime PCR was established. The expression of tumor suppressor gene LATS1 and LATS2 in 30 primary glioma tissues (WHO:GradeⅡ10 cases, Grade Ⅲ10 cases and Grade Ⅳ 10 cases) and 10 normal brain tissues were quantitated by the method of standard curve. The expression differences of LATS1 and LATS2 in different grade glioma compared with the normal brain tissues were studied and the relationship of the expression and the clinical data was also analyzed by a statistical method. Results: The expressions of LATS1 and LATS2were all significantly downregulated in different grade glioma compared with normal brain tissues (P<0.05). But there were no significant differences in the expression of LATS1 and LATS2 among the different grade glioma (P>0.05). And there were also no significant differences in different gender and age. Conclusions: The method to detect the expression of LATS1 and LATS2 by SYBR Green quantitative realtime PCR is established successfully. The tumor suppressor genes LATS1 and LATS2 are all downregulated in human glioma compared with those in the normal brain tissues.

Key words: Large tumor suppressor, homolog 1, Large tumor suppressor, homolog 2, Glioma, Realtime polymerase chainreaction, SYBR Green

[1] WANG Lin-Lin, SUN Mei-Li, SUN Yu-Ping, ZHANG Nan, LIU Chuan-Yong. Expressions of α-Tubulin and γ-Tubulin in human Glioma and their relation with Survivin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 103-.
[2] GUO Shuhua, FAN Yang, TIAN Feng, WANG Chuanxin, DU Lutao, LI Peilong, GUO Xing, XU Shuo. Role of microfibril-associated protein 3 in regulating mesenchymal transition of glioma stem cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 9-16.
[3] LI Xifeng, LI Hongmei. Cerebrospinal fluid CXCL10: a valuable biomarker for anti-NMDAR encephalitis [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 47-52.
[4] ZHU Zhengyang, SHEN Jingfei, CHEN Sixuan, YE Meiping, YANG Huiquan, ZHOU Jianan, LIANG Xue, ZHANG Xin, ZHANG Bing. Prediction of isocitrate dehydrogenase mutation in glioma with different radiomic models based on susceptibility-weighted imaging [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 44-50.
[5] YUAN Baowen, WANG Pei, HUANG Wei. Regulatory role of histone deacetylase SIRT1 in pancreatic cancer metabolism [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 1-12.
[6] LI Huayu, SHI Xiaohan, ZHANG Xinrui, LI Feng. Association between sleep disturbance and inflammatory cytokines in 203 patients with glioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 26-30.
[7] SUN Qingjie, ZHANG Yisha, GUAN Shanghui, FENG Zhihui. Effects of valproic acid on the survival and tumor recurrence of 134 patients with glioma treated with radiotherapy [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 80-85.
[8] GU Jinhai, LU Ning, GU Jiarong, WEN Yujun, QIANG Yuanyuan, HE Zhenquan, YANG Yong, WANG Feng, SUN Tao, NIU Jianguo. Effects of signal Crosstalk between glioma cells and vascular endothelial cells on the proliferation and invasion of glioma cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 1-6.
[9] SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60.
[10] LI Wenqing, YE Lan, JIANG Yuhua. CDK7 inhibitor THZ1 increases the radiosensitivity of human glioma cell line U251 [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 8-13.
[11] Gang LI,Hao XUE,Wei QIU,Rongrong ZHAO. Research advances in the formation of glioma immunosuppressive microenvironment [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 67-73.
[12] Qiang WU,Zekun HE,Ju LIU,Xiaomeng CUI,Shuang SUN,Wei SHI. A research on multi-modal MRI analysis based on machine learning for brain glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 81-87.
[13] Anjing CHEN,Xun ZHANG. The new strategies of targeting SUMOylation in the treatment of glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 88-94.
[14] Tao JIANG. The application of brain-like intelligence in the frontiers of brain science [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 10-13.
[15] XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!